SPY303.53+4.45 1.49%
DIA255.77+5.52 2.21%
IXIC9,412.36+72.14 0.77%

Castle Biosciences Q1 EPS $0.030 Beats $(0.150) Estimate, Sales $17.400M Beat $13.790M Estimate

Castle Biosciences (NASDAQ:CSTL) reported quarterly earnings of $0.030 per share which beat the analyst consensus estimate of $(0.150) by 120 percent. The company reported quarterly sales of $17.400 million which beat

Benzinga · 05/11/2020 20:20

Castle Biosciences (NASDAQ:CSTL) reported quarterly earnings of $0.030 per share which beat the analyst consensus estimate of $(0.150) by 120 percent. The company reported quarterly sales of $17.400 million which beat the analyst consensus estimate of $13.790 million by 26.18 percent.